Page last updated: 2024-09-04

abiraterone and Cancer of Testis

abiraterone has been researched along with Cancer of Testis in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, J; Dai, Y; Gao, Q1
Sonpavde, G; Sternberg, CN1

Reviews

1 review(s) available for abiraterone and Cancer of Testis

ArticleYear
Contemporary management of metastatic castration-resistant prostate cancer.
    Current opinion in urology, 2011, Volume: 21, Issue:3

    Topics: Androstenes; Androstenols; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Castration; Denosumab; Drug Therapy; Humans; Male; Prostatic Neoplasms; RANK Ligand; Taxoids; Testicular Neoplasms; Tissue Extracts

2011

Other Studies

1 other study(ies) available for abiraterone and Cancer of Testis

ArticleYear
Prostate cancer involving bilateral seminal vesicles along with bone and testicular metastases: a case report.
    Journal of medical case reports, 2018, Mar-09, Volume: 12, Issue:1

    Topics: Adenocarcinoma; Aged; Androgen Receptor Antagonists; Androstenes; Antineoplastic Agents, Hormonal; Bone Neoplasms; Humans; Male; Neoplasm Grading; Orchiectomy; Physical Examination; Prednisone; Prostate-Specific Antigen; Prostatic Neoplasms; Seminal Vesicles; Testicular Neoplasms; Tomography, X-Ray Computed

2018